Relevance of CYP17A1 Blockade in Clones of Castration-resistant Prostate Cancer

被引：0
|
作者：
Kumagai, J. [1 ]
Erkens-Schulze, S. [2 ]
Dits, N. F. J. [2 ]
de Wit, R. [3 ]
van Weerden, W. M. [1 ]
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Erasmus MC, Rotterdam, Netherlands
[3] Erasmus MC, Med Oncol, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72094-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
296
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [1] CYP17A1 inhibitors in castration-resistant prostate cancer
    Gomez, Lissette
    Kovac, Jason R.
    Lamb, Dolores J.
    STEROIDS, 2015, 95 : 80 - 87
  • [2] A Novel Communication Role for CYP17A1 in the Progression of Castration-Resistant Prostate Cancer
    Locke, Jennifer A.
    Fazli, Ladan
    Adomat, Hans
    Smyl, Jil
    Weins, Kristin
    Lubik, Amy A.
    Hales, Dale B.
    Nelson, Colleen C.
    Gleave, Martin E.
    Guns, Emma S. Tomlinson
    PROSTATE, 2009, 69 (09): : 928 - 937
  • [3] CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone
    Salvi, Samanta
    Casadio, Valentina
    Burgio, Salvatore Luca
    Conteduca, Vincenza
    Rossi, Lorena
    Menna, Cecilia
    Carretta, Elisa
    Costantini, Matteo
    Zoli, Wainer
    De Giorgi, Ugo
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2016, 31 (03): : E264 - E269
  • [4] Structure-based discovery of selective CYP17A1 inhibitors for Castration-resistant prostate cancer treatment
    Omoboyowa, Damilola A.
    Balogun, Toheeb A.
    Saibu, Oluwatosin A.
    Chukwudozie, Onyeka S.
    Alausa, Abdullahi
    Olubode, Samuel O.
    Aborode, Abdullahi T.
    Batiha, Gaber E.
    Bodun, Damilola S.
    Musa, Sekinat O.
    BIOLOGY METHODS & PROTOCOLS, 2022, 7 (01):
  • [5] HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer
    Almassi, Nima
    Reichard, Chad
    Li, Jianbo
    Russell, Carly
    Perry, Jaselle
    Ryan, Charles J.
    Friedlander, Terence
    Sharifi, Nima
    JAMA ONCOLOGY, 2018, 4 (04) : 554 - 557
  • [6] INTRACRINE DYNAMICS OF CYP17A1 ACTIVITIES IN HUMAN CASTRATION RESISTANT PROSTATE CANCER
    Kosaka, Takeo
    Miyajima, Akira
    Maeda, Takahiro
    Nagata, Hirohiko
    Yasumizu, Yota
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2013, 189 (04): : E207 - E208
  • [7] Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer
    Binder, Moritz
    Zhang, Ben Y.
    Hillman, David W.
    Kohli, Rhea
    Kohli, Tanvi
    Lee, Adam
    Kohli, Manish
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07)
  • [8] Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer
    Kosaka, Takeo
    Miyajima, Akira
    Yasumizu, Yota
    Miyazaki, Yasumasa
    Kikuchi, Eiji
    Oya, Mototsugu
    STEROIDS, 2014, 92 : 39 - 44
  • [9] Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
    Mostaghel, Elahe A.
    Marck, Brett T.
    Plymate, Stephen R.
    Vessella, Robert L.
    Balk, Stephen
    Matsumoto, Alvin M.
    Nelson, Peter S.
    Montgomery, R. Bruce
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 5913 - 5925
  • [10] ODM-204, a novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer.
    Kallio, Pekka
    Oksala, Riikka
    Moilanen, Anu
    Riikonen, Reetta
    Rummakko, Petteri
    Malmstrom, Chira
    Mustonen, Mika V. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345